Elizabeth Whittington

YAconnect, a new program from The Leukemia & Lymphoma Society, offers young adult cancer patients and survivors ways to connect online.

Supplement trial fails to show prevention benefit.

While several small studies have suggested the benefits of yoga in reducing the side effects of cancer treatment, the largest study to date is also the most definitive.

In two separate early-stage breast cancer studies, researchers examined the benefit of testing for traveling cancer cells that may have broken off the tumor site and additional surgery if those roaming cells were found.

Separate studies show that maintenance therapy, treatment given after initial therapy to prolong remission, can benefit patients with certain blood cancers.

An investigational drug, Crizotinib (PF-02341066), which targets a newly discovered gene mutation in lung tumors, showed dramatic results in a small phase 1 clinical trial of metastatic non-small cell lung cancer patients.

Interim results from a phase 3 trial showed that radiation added to androgen-deprivation therapy (ADT) increased overall survival and decreased the risk of death from prostate cancer.

A large randomized study contradicted that notion in advanced non-small cell lung cancer when data showed that the standard combination chemotherapy, usually given to younger patients, was effective and safe in elderly patients.

Updates results from the STAR trial show Evista and tamoxifen have long-term breast cancer prevention effects.

Updates results from the STAR trial show Evista and tamoxifen have long-term breast cancer prevention effects.

National Cancer Institute releases new Spanish-language materials.